119th Congress

H.R. 10227

INSULIN Act of 2026

Introduced
In committee
Passed House
Passed Senate
To President
Became law

Sponsor: Diana DeGette(D-CO)
Introduced: Sep 2, 2026
Policy area: Health
Committees: House Committee on Education and Workforce; House Committee on Energy and Commerce; House Committee on Ways and Means
Official text: Introduced in House · Congress.gov page

Cosponsors (19)

Original cosponsors (4)

Added later (15)

Joaquin Castro (D-TX) · Sep 8, 2026
John W. Mannion (D-NY) · Sep 8, 2026
Ryan Mackenzie (R-PA) · Sep 8, 2026
Emanuel Cleaver (D-MO) · Sep 14, 2026
Josh Riley (D-NY) · Sep 14, 2026
Nikki Budzinski (D-IL) · Sep 14, 2026
Sharice Davids (D-KS) · Sep 14, 2026
Glenn Ivey (D-MD) · Sep 21, 2026
Jahana Hayes (D-CT) · Sep 21, 2026
Chris Pappas (D-NH) · Sep 24, 2026
Gabe Vasquez (D-NM) · Sep 24, 2026
Pramila Jayapal (D-WA) · Sep 24, 2026
Rashida Tlaib (D-MI) · Sep 24, 2026
Suzan K. DelBene (D-WA) · Sep 24, 2026
Veronica Escobar (D-TX) · Oct 5, 2026

Summary

No Congressional Research Service summary yet. CRS usually publishes one a few weeks after a bill is introduced.

Official title: To reduce the price of insulin and provide for patient protections with respect to the cost of insulin.

Latest action(Sep 2, 2026): Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

Read the official text

Roll-call votes

No recorded votes on this bill.

Actions

Sep 2, 2026 · House
Referred to the Committee on Energy and Commerce, and in addition to the Committees on Ways and Means, and Education and Workforce, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.
Sep 2, 2026
Introduced in House